Topiramate's effects on cocaine-induced subjective mood, craving and preference for money over drug taking

Addiction Biology

Volumn 18, Issue 3, 2013, Pages 405-416

  Johnson, Bankole A ^a   Roache, John D ^b   Ait Daoud, Nassima ^a   Gunderson, Erik W ^a,c   Haughey, Heather M ^a   Wang, Xin Qun ^d   Liu, Lei ^a,e  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cocaine; craving; mood; preference; reward; topiramate

Indexed keywords

COCAINE; PLACEBO; TOPIRAMATE;

ADULT; ARTICLE; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; CROSSOVER PROCEDURE; EUPHORIA; FEMALE; HUMAN; MALE; MONEY; MOOD; PATIENT PREFERENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; AFFECT; COCAINE; COCAINE-RELATED DISORDERS; CROSS-OVER STUDIES; DOPAMINE UPTAKE INHIBITORS; DOUBLE-BLIND METHOD; EUPHORIA; FEMALE; FRUCTOSE; HUMANS; MALE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; PATIENT PREFERENCE; REINFORCEMENT (PSYCHOLOGY); YOUNG ADULT;

EID: 84876147734     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2012.00499.x     Document Type: Article

References (71)

1. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association.
2. Bell K, Kalivas PW, (1996) Context-specific cross-sensitization between systemic cocaine and intra-accumbens AMPA infusion in the rat. Psychopharmacology (Berl) 127: 377-383.
3. Cameron DL, Williams JT, (1994) Cocaine inhibits GABA release in the VTA through endogenous 5-HT. J Neurosci 14: 6763-6767.
4. Cervo L, Samanin R, (1995) Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Res 673: 242-250.
5. Chutuape MA, de Wit H, (1994) Relationship between subjective effects and drug preferences: ethanol and diazepam. Drug Alcohol Depend 34: 243-251.
6. Correll CU, Sheridan EM, DelBello MP, (2010) Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials. Bipolar Disord 12: 116-141.
7. Czuczwar SJ, Patsalos PN, (2001) The new generation of GABA enhancers: potential in the treatment of epilepsy. CNS Drugs 15: 339-350.
8. David V, Durkin TP, Cazala P, (1998) Rewarding effects elicited by microinjection of either AMPA or NMDA glutaminergic antagonists into the ventral tegmental area revealed by an intracranial self-administration paradigm in mice. Eur J Neurosci 10: 1392-1402.
9. de Vries TJ, Schoffelmeer AN, Binnekade R, Mulder AH, Vanderschuren LJ, (1998) MK-801 reinstates drug-seeking behaviour in cocaine-trained rats. Neuroreport 9: 637-640.
10. de Wit H, (2000) Laboratory-based assessment of alcohol craving in social drinkers. Addiction 95: S165-S169.
11. Dewey SL, Chaurasia CS, Chen CE, Volkow ND, Clarkson FA, Porter SP, (1997) GABAergic attenuation of cocaine-induced dopamine release and locomotor activity. Synapse 25: 393-398.
12. Di Paolo T, (1994) Modulation of brain dopamine transmission by sex steroids. Rev Neurosci 5: 27-41.
13. Fischman MW, Foltin RW, (1991) Utility of subjective-effects measurements in assessing abuse liability of drugs in humans. Br J Addict 86: 1563-1570.
14. Foltin RW, Fischman MW, (1991) Smoked and intravenous cocaine in humans: acute tolerance, cardiovascular and subjective effects. J Pharmacol Exp Ther 257: 247-261.
15. Foltin RW, Fischman MW, (1992) Self-administration of cocaine by humans: choice between smoked and intravenous cocaine. J Pharmacol Exp Ther 261: 841-849.
16. Gibbs JW, Sombati S, DeLorenzo RJ, Coulter DA, (2000) Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons. Epilepsia 41 (Suppl 1): S10-S16.
17. Griffiths RR, Balster RL, (1979) Opioids: similarity between evaluations of subjective effects and animal self-administration results. Clin Pharmacol Ther 25: 611-617.
18. Griffiths RR, Rush CR, Puhala KA, (1996) Validation of the multiple-choice procedure for investigating drug reinforcement in humans. Exp Clin Psychopharmacol 4: 97-106.
19. Griffiths RR, Troisi JR, Silverman K, Mumford GK, (1993) Multiple-choice procedure: an efficient approach for investigating drug reinforcement in humans. Behav Pharmacol 4: 3-13.
20. Haertzen CA, Hill HE, Belleville RE, (1963) Development of the Addiction Research Center Inventory (ARCI): selection of items that are sensitive to the effects of various drugs. Psychopharmacologia 4: 155-166.
21. Haney M, Spealman R, (2008) Controversies in translational research: drug self-administration. Psychopharmacology (Berl) 199: 403-419.
22. Hemby SE, Johnson BA, Dworkin SI, (1997) Neurobiological basis of drug reinforcement. In:, Johnson BA, Roache JD, eds. Drug Addiction and Its Treatment: Nexus of Neuroscience and Behavior, pp. 137-169. Philadelphia, PA: Lippincott-Raven.
23. Highfield DA, Mead AN, Grimm JW, Rocha BA, Shaham Y, (2002) Reinstatement of cocaine seeking in 129X1/SvJ mice: effects of cocaine priming, cocaine cues and food deprivation. Psychopharmacology (Berl) 161: 417-424.
24. Hollingshead AB, Redlich FC, (1958) Social Class and Mental Illness: A Community Study. New York: Wiley.
25. Hughes JR, Alison HO, Terry SY, (1996) Saying versus doing and other methodological issues in the study of drug self-administration. Exp Clin Psychopharmacol 4: 234-238.
26. Jasinski DR, Johnson RE, Henningfield JE, (1984) Abuse liability assessment in human subjects. Trends Pharmacol Sci 5: 196-200.
27. Johnson B, Barron B, Fang B, Lamki L, Wagner L, Wells L, Kenny P, Overton D, Dhother S, Abramson D, Chen R, Kramer L, (1998a) Isradipine prevents global and regional cocaine-induced changes in brain blood flow: a preliminary study. Psychopharmacology (Berl) 136: 335-341.
28. Johnson B, Lamki L, Fang B, Barron B, Wagner L, Wells L, Kenny P, Overton D, Dhother S, Abramson D, Chen R, Kramer L, (1998b) Demonstration of dose-dependent global and regional cocaine-induced reductions in brain blood flow using a novel approach to quantitative single photon emission computerized tomography. Neuropsychopharmacology 18: 377-384.
29. Johnson BA, Ait-Daoud N, (2010) Topiramate in the new generation of drugs: efficacy in the treatment of alcoholic patients. Curr Pharm Des 16: 2103-2112.
30. Johnson BA, Oldman D, Goodall EM, Chen YR, Cowen PJ, (1996) Effects of GR 68755 on d-amphetamine-induced changes in mood, cognitive performance, appetite, food preference, and caloric and macronutrient intake in humans. Behav Pharmacol 7: 216-227.
31. Johnson BA, Roache JD, Ait-Daoud N, Wells LT, Mauldin JB, (2004) Effects of isradipine on cocaine-induced subjective mood. J Clin Psychopharmacol 24: 180-191.
32. Johnson BA, Roache JD, Ait-Daoud N, Wells LT, Wallace CL, Dawes MA, Liu L, Wang X-Q, (2007a) Effects of acute topiramate dosing on methamphetamine- induced subjective mood. Int J Neuropsychopharmacol 10: 85-98.
33. Johnson BA, Roache JD, Bordnick PS, Ait-Daoud N, (1999) Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphetamine's positive subjective effects: a preliminary study. Psychopharmacology (Berl) 144: 295-300.
34. Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L, Beyers K, McKay A, Ait-Daoud N, Anton RF, Ciraulo DA, Kranzler HR, Mann K, O'Malley SS, Swift RM, Topiramate for Alcoholism Advisory Board, Topiramate for Alcoholism Study Group (2007b) Topiramate for treating alcohol dependence: a randomized controlled trial. JAMA 298: 1641-1651.
35. Kaddis FG, Uretsky NJ, Wallace LJ, (1995) DNQX in the nucleus accumbens inhibits cocaine-induced conditioned place preference. Brain Res 697: 76-82.
36. Kalivas PW, Churchill L, Klitenick MA, (1993) GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neuroscience 57: 1047-1060.
37. Kampman KM, Pettinati H, Lynch KG, Dackis C, Sparkman T, Weigley C, O'Brien CP, (2004) A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend 75: 233-240.
38. Karler R, Calder LD, Thai DK, Bedingfield JB, (1998) The role of dopamine and GABA in the frontal cortex of mice in modulating a motor stimulant effect of amphetamine and cocaine. Pharmacol Biochem Behav 60: 237-244.
39. King TS, Steger RW, Morgan WW, (1986) Effect of ovarian steroids to stimulate region-specific hypothalamic 5-hydroxytryptamine synthesis in ovariectomized rats. Neuroendocrinology 42: 344-350.
40. Koob GF, (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13: 177-184.
41. Li Y, Vartanian AJ, White FJ, Xue CJ, Wolf ME, (1997) Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine. Psychopharmacology (Berl) 134: 266-276.
42. Maxwell SE, Delaney HD, (1990) Designing Experiments and Analyzing Data: A Model Comparison Perspective. Pacific Grove, CA: Brooks/Cole.
43. McNair DM, Lorr M, Droppleman LF, (1971) Manual of the Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service.
44. Moghaddam B, Bolinao ML, (1994) Glutamatergic antagonists attenuate ability of dopamine uptake blockers to increase extracellular levels of dopamine: implications for tonic influence of glutamate on dopamine release. Synapse 18: 337-342.
45. Mumford GK, Rush CR, Griffiths RR, (1995) Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects. J Pharmacol Exp Ther 272: 570-580.
46. Newton TF, Kalechstein AD, Tervo KE, Ling W, (2003) Irritability following abstinence from cocaine predicts euphoric effects of cocaine administration. Addict Behav 28: 817-821.
47. Pap A, Bradberry CW, (1995) Excitatory amino acid antagonists attenuate the effects of cocaine on extracellular dopamine in the nucleus accumbens. J Pharmacol Exp Ther 274: 127-133.
48. Peris J, (1996) Repeated cocaine injections decrease the function of striatal gamma-aminobutyric acid(A) receptors. J Pharmacol Exp Ther 276: 1002-1008.
49. Petroff OA, Hyder F, Mattson RH, Rothman DL, (1999) Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy. Neurology 52: 473-478.
50. Petroff OA, Hyder F, Rothman DL, Mattson RH, (2001) Topiramate rapidly raises brain GABA in epilepsy patients. Epilepsia 42: 543-548.
51. Preston KL, Vahabzadeh M, Schmittner J, Lin JL, Gorelick DA, Epstein DH, (2009) Cocaine craving and use during daily life. Psychopharmacology (Berl) 207: 291-301.
52. Preston KL, Walsh SL, Sannerud CA, (1997) Measures of interoceptive stimulus effects: relationship to drug reinforcement. In:, Johnson BA, Roache JD, eds. Drug Addiction and Its Treatment: Nexus of Neuroscience and Behavior, pp. 91-114. Philadelphia, PA: Lippincott-Raven.
53. Reis AD, Castro LA, Faria R, Laranjeira R, (2008) Craving decrease with topiramate in outpatient treatment for cocaine dependence: an open label trial. Rev Bras Psiquiatr 30: 132-135.
54. Roache JD, (2010) Role of the human laboratory in the development of medications for alcohol and drug dependence. In:, Johnson BA, ed. Addiction Medicine: Science and Practice, pp. 129-157. New York: Springer Science + Business Media, LLC.
55. Roache JD, Griffiths RR, (1989) Diazepam and triazolam self-administration in sedative abusers: concordance of subject ratings, performance and drug self-administration. Psychopharmacology (Berl) 99: 309-315.
56. Roache JD, Johnson BA, Ait-Daoud N, Mauldin JB, Thornton JE, Wells LT, Murff WL, (2005) Effects of repeated-dose isradipine on the abuse liability of cocaine. Exp Clin Psychopharmacol 13: 319-326.
57. Roache JD, Meisch RA, (1995) Findings from self-administration research on the addiction potential of benzodiazepines. Psychiatr Ann 25: 153-157.
58. Rockhold RW, (1998) Glutamatergic involvement in psychomotor stimulant action. Prog Drug Res 50: 155-192.
59. Schiffer WK, Gerasimov MR, Marsteller DA, Geiger J, Barnett C, Alexoff DL, Dewey SL, (2001) Topiramate selectively attenuates nicotine-induced increases in monoamine release. Synapse 42: 196-198.
60. Schneiderman JH, (1998) Topiramate: pharmacokinetics and pharmacodynamics. Can J Neurol Sci 25: S3-S5.
61. Silverstone PH, Oldman D, Johnson B, Cowen PJ, (1992) Ondansetron, a 5-HT3 receptor antagonist, partially attenuates the effects of amphetamine: a pilot study in healthy volunteers. Int Clin Psychopharmacol 7: 37-43.
62. Skradski S, White HS, (2000) Topiramate blocks kainate-evoked cobalt influx into cultured neurons. Epilepsia 41 (Suppl 1): S45-S47.
63. Sofuoglu M, Waters AJ, Mooney M, O'Malley SS, (2009) Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans. Pharmacol Biochem Behav 92: 135-140.
64. Weiss RD, Griffin ML, Hufford C, (1995) Craving in hospitalized cocaine abusers as a predictor of outcome. Am J Drug Alcohol Abuse 21: 289-301.
65. Wheeler RA, Aragona BJ, Fuhrmann KA, Jones JL, Day JJ, Cacciapaglia F, Wightman RM, Carelli RM, (2011) Cocaine cues drive opposing context-dependent shifts in reward processing and emotional state. Biol Psychiatry 69: 1067-1074.
66. White HS, Brown SD, Woodhead JH, Skeen GA, Wolf HH, (1997) Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res 28: 167-179.
67. Witkin JM, (1993) Blockade of the locomotor stimulant effects of cocaine and methamphetamine by glutamate antagonists. Life Sci 53: L405-L410.
68. Wolf ME, (1998) The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54: 679-720.
69. Woods JH, Katz JL, Winger G, (1987) Abuse liability of benzodiazepines. Pharmacol Rev 39: 251-413.
70. Zhang XF, Hu XT, White FJ, Wolf ME, (1997) Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors. J Pharmacol Exp Ther 281: 699-706.
71. Zullino DF, Khazaal Y, Hättenschwiler J, Borgeat F, Besson J, (2004) Anticonvulsant drugs in the treatment of substance withdrawal. Drugs Today 40: 603-619.